Discontinuation report APO-BRIMONIDINE

Last updated on 2020-11-16 History
Report ID 128438
Drug Identification Number 02260077
Brand name APO-BRIMONIDINE
Common or Proper name APO-BRIMONIDINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) BRIMONIDINE TARTRATE
Strength(s) 0.2%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 10mL and 5mL
ATC code S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-04-17
Remaining supply date 2020-04-17
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-11-16 French Compare
v1 2020-11-16 English Compare